Advancing the development and manufacture of therapeutics

We are a global provider of technologies and services that advance and accelerate the development, manufacture, and delivery of therapeutics. Our rich heritage dates back hundreds of years, and we got a fresh start in 2020 as a standalone operating company in the Danaher Corporation.

Our customers undertake life-saving activities ranging from biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Our job is to supply the tools and services they need to work better, faster, and safer, leading to better patient outcomes.

Cytiva at a glance






manufacturing sites


years in the biopharma supply industry


recognized in antibody purification


innovation centers

Let's work together to advance future therapeutics

With the majority of mAbs approved by the FDA in 2020 using Cytiva technologies in manufacture, we're proud to be making a difference in healthcare. Our commitment to consistent and dependable solutions will help deliver life-saving therapies.

Biopharma is evolving. Cytiva is here to help

Personalized and novel therapies are changing the treatment landscape at a rapid pace. With 4 of the 5 approved CAR-T cell therapies including Cytiva solutions, we are helping our customers adapt to industry trends and bring these therapeutics to market.